T32 Integrative Training in Oncogenic Signaling (ITOS):
Fellows

Current Fellows

Toros Dincman, M.D., Ph.D.

Toros Dincman, M.D., Ph.D.

Research Interests: Evaluating Interleukin-like EMT Inducer's (ILEI) role in therapeutic sensitivity in lung cancer.

Research Aims: My research aims are to further our understanding on cancer pathogenesis and identify clinically applicable treatment paradigms in hopes of improving patient survival.

Mentor: Philip Howe, Ph.D.

Denise Garcia, M.D.

Denise Garcia, M.D.

Research Interests: Development of alternate cancer immunotherapies in aggressive and therapy-resistant cancers.

Research Aims: My research will investigate the efficacy of novel alternative immunotherapies in aggressive cancer treatment and their mechanisms of action with regards to the tumor signaling pathway. I will also investigate the impact of combination immunotherapies on cancer growth, proliferation, and invasion.

Mentor: Nancy DeMore, M.D.

Lu Han, Ph.D.

Lu Han, Ph.D.

Research Interests: Cellular Interaction and Coordination between Epithelium and Mesenchyme during Development and Cancer.

Research Aims: My research aims to develop innovative perspectives to exploit the similarities and tease apart the differences between the embryonic developmental processes and cancer progression. With a particular interest in the tissue resident fibroblast, I aim to uncover novel cellular interactions in the tumor microenvironment, which ultimately could serve as therapeutic targets.

Mentor: Gustavo Leone, Ph.D.

Catherine MarElia

Catherine MarElia, Ph.D.

Research Interests: Elucidating Mechanisms of Stromal Fibroblasts’ Impact on Tumor Cells in Pancreatic Cancer.

Research Aims: The aim of my research is to interrogate the effects of conditional expression of important signaling pathway members, such as IL-6, within the stromal fibroblasts on tumor cells to gain insight into the disparate pathophysiological effects of spatially distinct expression of these effectors during the progression of pancreatic adenocarcinoma.

Mentor: Michael Ostrowski, Ph.D.

Kelly Wolfe, Ph.D.

Kelly Wolfe, Ph.D.

Research Interests: Ubiquitin Signaling during DNA Interstrand Crosslink Repair

Research Aims: Defects in interstrand crosslink repair can lead to Fanconi Anemia and hereditary breast and ovarian cancers. My research will explore how ICL repair is influenced by atypical ubiquitin linkages and use basic biology to provide insight into human health and disease.

Mentor: David Long, Ph.D.

Past Fellows

James Atkison, Ph.D.

James Atkison, Ph.D.

Research Interests: Investigation of the Structure and Role of the Nephila clavipes Major Ampullate Spidroin 1A N-terminal Domain

Research Aims:My long-term career goal is to work in the biomedical industry and discover life-saving devices and drugs to be used in cancer therapies. I hope to contribute to the ever-growing field of cancer therapeutics by investigating small molecule interactions for future drug development.

Mentor: Shaun Olsen, Ph.D.

Annamarie Dalton

Annamarie Dalton, Ph.D.

Research Interests: Interleukin-like EMT Inducer (ILEI) Signaling in Metastatic Breast Cancer

Research Aims: Previously, my research focused on structural and biophysical characterization of the Tie2 endothelial specific receptor. Through the ITOS program, I hope to integrate techniques learned during my PhD training with in-depth signaling evaluation in vivo to further knowledge in breast cancer pathobiology.

Mentor: Philip Howe, Ph.D.

Stephen Iwanowycz

Stephen Iwanowycz, Ph.D.

Research Interests: Role of Innate Immune Cells in the Tumor Microenvironment

Research Aims: I am passionate about using science to advance precision medicine. I would like to build my research around investigating the signaling between the different cell types within tumors in order to develop targeted therapies to reverse immune suppression.

Mentor: Bei Liu, M.D.

Reeder Robinson

Reeder Robinson, Ph.D.

Research Interests: Development of Experimental Therapeutics Against Multiple Myeloma

Research Aims: My research aims are to discover the target of our lead experimental compound E61, a compound that is synergistic with proteasome inhibitors in Multiple Myeloma, and to develop a more efficacious and metabolically stable derivative that we can move into clinical trials.

Mentor: Nathan Dolloff, Ph.D.

Lawton Roberts

Lawton Roberts, Ph.D.

Research Interests: The Unfolded Protein Response (UPR) and Sphingolipid Metabolism in Cancer Cell Biology

Research Aims: As my research focus is in cancer cell biology, I aim to use cancer cell models and rodents, genetic techniques/manipulation, and confocal microcopy to address compelling questions in cancer biology research in an effort to specifically understand the effects of mycobacterium tuberculosis and interleukin-27 on human dendridic cells.

Mentor: J. Alan Diehl, Ph.D.

Back to top Back to top